DR. FRANK CHARLES PASSERO JR. M.D.
Prescription History 1982928636
Internal Medicine - Hematology & Oncology in Rochester, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. FRANK CHARLES PASSERO JR. M.D., an active Hematology & Oncology specialist practicing in Rochester, NY. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 605 documented patient claims. Among these therapy options, the most frequently utilized medication is Acyclovir, which accounts for 112 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Acyclovir | 112 | $12.86▼ below NY avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 112 Medicare prescriptions for Acyclovir, about 4.1 times the volume of the typical New York prescriber of this medication (27). Medicare paid an average of $12.86 per fill, versus $49.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 132 30-Day Fills standardized to 30-day supplies 3,804 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 104 | $19,918.76 | ▲ More than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 104 Medicare prescriptions for Revlimid, about 2.5 times the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $19,918.76 per fill, versus $18,578.11 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 104 30-Day Fills standardized to 30-day supplies 2,870 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 103 | $21.03 | ▲ More than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 103 Medicare prescriptions for Dexamethasone, about 4 times the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $21.03 per fill, versus $16.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 136.3 30-Day Fills standardized to 30-day supplies 3,448 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 86 | $16,694.19 | ▲ More than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 86 Medicare prescriptions for Lenalidomide, about 4.3 times the volume of the typical New York prescriber of this medication (20). Medicare paid an average of $16,694.19 per fill, versus $14,905.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 86 30-Day Fills standardized to 30-day supplies 2,408 Days of Medication total across all patients in 2023 | |||
| PomalystPomalidomide | 62 | $22,643.81 | ▲ More than typical |
About Pomalyst: Pomalidomide is used to treat certain types of cancers (such as multiple myeloma, Kaposi sarcoma). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 62 Medicare prescriptions for Pomalyst, about 2.1 times the volume of the typical New York prescriber of this medication (30). Medicare paid an average of $22,643.81 per fill, versus $19,958.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62 30-Day Fills standardized to 30-day supplies 1,736 Days of Medication total across all patients in 2023 | |||
| NinlaroIxazomib Citrate | 34 | $12,479.85 | ▲ More than typical |
About Ninlaro: This medication is used to treat a certain type of cancer (multiple myeloma). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 34 Medicare prescriptions for Ninlaro, about 1.4 times the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $12,479.85 per fill, versus $12,435.15 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 952 Days of Medication total across all patients in 2023 | |||
| VyndamaxTafamidis | 34 | $21,391.57▼ below NY avg | ≈ Typical |
About Vyndamax: This medication is used to treat a certain type of heart failure (transthyretin-mediated amyloidosis). Show more ▾ It is used to help prevent the heart failure from getting worse and needing treatment in a hospital. Tafamidis works by slowing the buildup of a certain protein (amyloid fibrils) that causes heart problems. In 2023, this provider wrote 34 Medicare prescriptions for Vyndamax, about the same volume as the typical New York prescriber of this medication (36). Medicare paid an average of $21,391.57 per fill, versus $25,825.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 22 | $561.08▼ below NY avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 22 Medicare prescriptions for Eliquis, about a third of the volume of the typical New York prescriber of this medication (78). Medicare paid an average of $561.08 per fill, versus $816.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| Budesonide DrBudesonide | 17 | $342.63 | ≈ Typical |
About Budesonide Dr: Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed. A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS. In 2023, this provider wrote 17 Medicare prescriptions for Budesonide Dr, about 85% of the volume of the typical New York prescriber of this medication (20). Medicare paid an average of $342.63 per fill, versus $232.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Montelukast Sodium | 17 | $1.19▼ below NY avg | ▼ Less than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. In 2023, this provider wrote 17 Medicare prescriptions for Montelukast Sodium, about a third of the volume of the typical New York prescriber of this medication (55). Medicare paid an average of $1.19 per fill, versus $15.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 17 30-Day Fills standardized to 30-day supplies 454 Days of Medication total across all patients in 2023 | |||
| Atovaquone | 14 | $471.03▼ below NY avg | ▼ Less than typical |
About Atovaquone: Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). Show more ▾ This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath. A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols. In 2023, this provider wrote 14 Medicare prescriptions for Atovaquone, about 61% of the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $471.03 per fill, versus $925.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 14 30-Day Fills standardized to 30-day supplies 303 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. FRANK CHARLES PASSERO JR. M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Rochester, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
